Aventis's Merilog (insulin-aspart-szjj) as a biosimilar to Novolog (insulin aspart) for adults and pediatric patients with ...
The FDA has approved Merilog (insulin-aspart-szjj), a biosimilar to Novolog, to improve glycemic control in patients with diabetes mellitus.
People with type 1 diabetes require continuous insulin treatment and must regularly measure their glucose levels. With open-loop therapies*, insulin administration is manually controlled, while hybrid ...
Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ), a clinical-stage biotechnology company advancing regenerative medicine solutions, today announced ...
The Food and Drug Administration said Wednesday it has received multiple ... field of wearable devices that track patients’ sugar levels or automatically deliver insulin, the hormone that helps manage ...
Trump administration officials are taking major steps to cut down ... By Monday, all OPM offices are expected to give political leaders organizational staffing charts with plans for an initial 30% ...
“Pluristyx is proud to support Humacyte as they develop the BioVascular Pancreas, a highly needed organ system for the treatment of insulin ... by the Food and Drug Administration or any global ...
By Michael Crowley and Edward Wong Reporting from Washington The Trump administration placed several dozen senior officials at the U.S. Agency for International Development on administrative leave ...
In the kitchen of her South St. Paul home, Abigail Turner prepares the insulin she uses to manage her type 1 diabetes last February. Minnesota announced a final settlement Monday with the last of ...
As of Jan. 27, there has been no presidential action, opens new tab under the Trump administration to change or remove the $35 insulin cap as outlined in the IRA. In another executive order ...
The lawyers were part of former special counsel Jack Smith's team which brought two cases against Trump US President Donald Trump's administration has fired more than a dozen justice department ...
(ABC 6 News) – On Monday, Attorney General Keith Ellison announced a settlement with Novo Nordisk that let’s Minnesotans buy its insulin products for $35 per month. For the next five years ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results